- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19.01. | Simris Group AB: Bulletin from Simris Group AB's extraordinary general meeting | 175 | GlobeNewswire (Europe) | Simris Group AB (publ), reg. no. 556841-9187 (the "Company"), held an extraordinary general meeting on 19 January 2026. Below follows a summary of the resolutions that were passed at the general meeting.
Election... ► Artikel lesen | |
| 12.11.25 | Simris Group AB receives observation status | 148 | GlobeNewswire | Today, November 12, 2025, Simris Group AB (the "Company") disclosed its interim report for the third quarter of 2025 with information on the Company's financial situation.
The rules of Nasdaq... ► Artikel lesen | |
| SIMRIS GROUP Aktie jetzt für 0€ handeln | |||||
| 12.11.25 | Simris Group AB: Simris Group Interim Report January-september 2025 | 174 | GlobeNewswire (Europe) | QUARTER 3, JULY - SEPTEMBER 2025Net revenue decreased by 37% to SEK 484k (766k).EBITDA declined by 22% to SEK -3 639k (-2 971k).EBIT/Operating result declined by 8% to SEK -7 152k (-6 614k).INTERIM... ► Artikel lesen | |
| 10.11.25 | Simris Group AB: Simris Group announces leadership transition - Daniel Kubitza appointed interim CEO | 202 | GlobeNewswire (Europe) | The Board of Directors of Simris Group has appointed Daniel Kubitza as interim CEO, effective immediately.
Daniel Kubitza has over 20 years of experience in corporate financing, commercialization and... ► Artikel lesen | |
| 05.11.25 | Simris Group AB: Simris Group AB Announces Positive Results from Ongoing Antibody-Drug Conjugate (ADC) Study with Nuvisan | 185 | GlobeNewswire (Europe) | Simris Group AB's wholly owned subsidiary, Simris Biologics GmbH, today announced important progress in its ongoing preclinical study with Nuvisan, a leading European contract research and development... ► Artikel lesen | |
| 06.10.25 | Simris Group AB: Update Regarding In-Vitro Evaluation of Novel Advance Microcystin Payloads | 245 | GlobeNewswire (Europe) | Simris Group AB wholly owned subsidiary, Simris Biologics GmbH, today announced short technical delays in a previously announced study contracted with Nuvisan, a leading European contract research and... ► Artikel lesen | |
| 12.09.25 | Simris Group AB: Simris Biologics awarded €200K in non-dilutive funding for R&D programme to further develop microcystin payloads for Antibody Drug Conjugates (ADCs) | 882 | GlobeNewswire (Europe) | Simris Group AB, a pioneer in the development of novel, next-generation Antibody Drug Conjugate (ADC) payloads based on Microcystin (MC) toxin variants, announces that funding has been approved for... ► Artikel lesen | |
| 13.08.25 | Simris Group AB: Simris Group Interim Report January-june 2025 | 223 | GlobeNewswire (Europe) | QUARTER 2, APRIL - JUNE 2025Net revenue increased by 8% to SEK 687k (634k).EBITDA improved by 51% to SEK -2 980k (-6 117k).EBIT/Operating result improved by 32% to SEK -6 693k (-9 822k).INTERIM PERIOD... ► Artikel lesen | |
| 14.07.25 | Simris Group AB: Partner Company Decides Not to Proceed with Simris Group ADC Proposed Collaboration Following Strategic Review | 219 | GlobeNewswire (Europe) | Simris Group AB (publ), through its subsidiary Simris Biologics GmbH, announces that the EU-based biopharmaceutical company with which it had signed a non-binding concept sheet for a potential antibody-drug... ► Artikel lesen | |
| 28.05.25 | Simris Group AB: Bulletin from Simris Group AB's annual general meeting | 333 | GlobeNewswire (Europe) | Simris Group AB (publ), reg. no. 556841-9187 (the "Company"), held its annual general meeting on 28 May 2025. Below follows a summary of the resolutions that were passed at the general meeting.
Income... ► Artikel lesen | |
| 14.05.25 | Simris Group AB: Simris Group Interim Report January-march 2025 | 404 | GlobeNewswire (Europe) | QUARTER 1, JANUARY - MARCH 2025Net revenue decreased by 69 percent to SEK 159k (519k).EBITDA improved by 30 percent to SEK -3 724k (-5 325k). EBIT/ operating result improved by 19 percent to SEK -7... ► Artikel lesen | |
| 26.02.25 | Simris Group AB: Simris Group Year-end Report January-december 2024 | 259 | GlobeNewswire (Europe) | QUARTER 4, OCTOBER - DECEMBER 2024Net revenue decreased by 63 percent to SEK 971k (2 657k).EBITDA improved by 41 percent to SEK -3 180k (-5 403k).EBIT/Operating result deteriorate by 6 percent to SEK... ► Artikel lesen |
12 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BEYOND MEAT | 0,601 | -4,82 % | BEYOND MEAT INC zeigt strukturelle Stärke | ||
| OATLY GROUP | 10,350 | +9,64 % | Oatly Reports First Profitable Year, Plans To Accelerate Growth Strategy | ||
| CONAGRA BRANDS | 16,856 | +3,75 % | Conagra Brands rolls out breakfast bowls: The Banquet-brand prepared meals offer 30 grams of protein | ||
| AGRARIUS | - | - | Agrarius AG: "Konzernjahresfehlbetrag sinkt von 2,37 auf 1,98 Mio. Euro - 221 Hektar Ackerland im Eigentum" - HV-Bericht von GSC-Research | - im Anhang finden Sie den HV-Bericht von GSC-Research.Anhang: HVAGRARIUS2025.pdfDen vollständigen Artikel lesen ... ► Artikel lesen | |
| WINGSTOP | 206,00 | -6,36 % | Wingstop-Aktie: TD Cowen bestätigt Halteempfehlung für den "Battleground Stock" | ||
| WH GROUP | 1,090 | +6,86 % | HSI Closes at 27,266, Up 83 pts; HSTI Closes at 5,499, Up 48 pts; XIAOMI Up over 4%; TECHTRONIC IND, CHINA RES MIXC, ZTO EXPRESS-W, WH GROUP, CLP HOLDINGS Hit New Highs; Market Turnover Rises | ||
| MHP | 7,050 | +4,44 % | Ukraine's MHP places $100 mln 2029 Eurobonds at 104% of par | ||
| JACK IN THE BOX | 18,300 | +6,40 % | Jack in the Box fordert Aktionäre zur Unterstützung des Verwaltungsrats im Konflikt mit Biglari auf | ||
| ELSE NUTRITION | 0,052 | +2,17 % | Else Nutrition Holdings Inc.: Else Nutrition Announces Results from Annual General Meeting of Shareholders | VANCOUVER, BC, Jan. 12, 2026 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL) (the "Company") announces that at its annual general... ► Artikel lesen | |
| J&J SNACK FOODS | 68,00 | -0,73 % | J&J Snack introduces protein-packed pretzels: First-of-its-kind products part of SuperPretzel brand | ||
| BIOGAIA | 10,250 | -0,29 % | BioGaia AB: BioGaia's results for the fourth quarter to exceed market expectations | (Figures in the brackets refer to the same period the previous year)
During the fourth quarter of 2025, BioGaia's sales were positively affected by quarterly variations for individual orders of approximately... ► Artikel lesen | |
| PP LONDON SUMATRA INDONESIA | 0,049 | +2,08 % | XFRA NEW INSTRUMENTS AVAILABLE ON 08.12.2025 | The following instruments on XETRA do have their first trading 08.12.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 08.12.2025
Aktien
1 KYG4600C1107 Hope Life International... ► Artikel lesen | |
| CAVA GROUP | 67,34 | -2,29 % | P/E Ratio Insights for Cava Group | ||
| KRAFT HEINZ | 20,970 | 0,00 % | Ihre wichtigsten Termine: Frische Zahlen von: McDonald's, Kraft Heinz, T-Mobile US und Thyssenkrupp Nucera | © Foto: Christoph Schmidt/dpaGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine 06:00... ► Artikel lesen | |
| ONCE UPON A FARM | 22,475 | +5,76 % | New York Stock Exchange: NYSE Content Update: Children's Food Brand Once Upon a Farm to Open for Trade | NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, Feb. 6, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly... ► Artikel lesen |
SIMRIS GROUP AB gehört der Branche Nahrungsmittel/Agrar an. Mit einer aktuellen Kursveränderung von -0,003 (-23,64 %) liegt der Kurs bei 0,008 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SIMRIS GROUP AB finden Sie auf Wallstreet Online.